DNA Polymerases as Potential Therapeutic Targets for Cancers Deficient in the DNA Mismatch Repair Proteins MSH2 or MLH1
Open Access
- 16 March 2010
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 17 (3), 235-248
- https://doi.org/10.1016/j.ccr.2009.12.046
Abstract
No abstract availableThis publication has 60 references indexed in Scilit:
- Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2EMBO Molecular Medicine, 2009
- Novel DNA mismatch-repair activity involving YB-1 in human mitochondriaDNA Repair, 2009
- Principles of Cancer Therapy: Oncogene and Non-oncogene AddictionCell, 2009
- Human MutL-complexes monitor homologous recombination independently of mismatch repairDNA Repair, 2009
- γH2AX and cancerNature Reviews Cancer, 2008
- Two distinct pathways of cell death triggered by oxidative damage to nuclear and mitochondrial DNAsThe EMBO Journal, 2008
- Decreased mtDNA, oxidative stress, cardiomyopathy, and death from transgenic cardiac targeted human mutant polymerase γLaboratory Investigation, 2007
- The multifaceted mismatch-repair systemNature Reviews Molecular Cell Biology, 2006
- The Concept of Synthetic Lethality in the Context of Anticancer TherapyNature Reviews Cancer, 2005
- A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancerOncogene, 1999